FABP1 and metabolic dysfunction-associated steatotic liver disease: To examine the effect of FABP1 knockdown on NAFLD, we generated adenovirus expressing shRNA for mouse FABP1 and injected it into HFD‐fed C57BL/6J mice via the tail vein.